Viewing Study NCT03188159


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-02-25 @ 11:05 PM
Study NCT ID: NCT03188159
Status: UNKNOWN
Last Update Posted: 2018-03-29
First Post: 2017-03-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
Sponsor: National University Hospital, Singapore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
Keywords: